IL1B and Alzheimer disease: In our study cohort, the CSF IL-1β levels of AD patients (0.54 / 0.27–0.82 pg/ml) showed no change compared to non-demented elderly control subjects (0.33 / 0.24–0.53 pg/ml; p = 0.12) (Fig. 1a).